Intellinetics, Inc. (NYSEAMERICAN:INLX – Get Free Report)’s stock price shot up 0.4% during mid-day trading on Friday . The company traded as high as $6.25 and last traded at $6.2760. 3,415 shares traded hands during trading, an increase of 157% from the average session volume of 1,330 shares. The stock had previously closed at $6.25.
Intellinetics Stock Up 0.4%
The business’s 50 day simple moving average is $7.06 and its 200-day simple moving average is $7.71. The company has a market cap of $28.18 million, a price-to-earnings ratio of -11.84 and a beta of 0.16. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.87 and a current ratio of 0.90.
Intellinetics (NYSEAMERICAN:INLX – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.22). Intellinetics had a negative net margin of 14.31% and a negative return on equity of 16.89%. The business had revenue of $3.91 million during the quarter, compared to analyst estimates of $4.55 million.
Institutional Investors Weigh In On Intellinetics
About Intellinetics
Intellinetics, Inc is a provider of enterprise content management and digital transformation solutions designed to help organizations streamline document-centric processes and improve operational efficiency. The company’s platform enables clients to capture, store, manage and retrieve both paper and electronic records through a unified system, reducing reliance on manual workflows and minimizing the risks associated with paper-based information handling.
The company offers a range of software products and professional services aimed at automating business processes and ensuring secure, compliant access to critical data.
Read More
- Five stocks we like better than Intellinetics
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
- 3 ETFs For the Coming Genomics Revolution
Receive News & Ratings for Intellinetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellinetics and related companies with MarketBeat.com's FREE daily email newsletter.
